КОМОРБІДНІСТЬ ТА ЇЇ ВПЛИВ НА ПРИХИЛЬНІСТЬ ДО ПОДАЛЬШОГО ЛІКУВАННЯ У ПАЦІЄНТІВ З ІНФАРКТОМ МІОКАРДА

O. I. Levchyk
{"title":"КОМОРБІДНІСТЬ ТА ЇЇ ВПЛИВ НА ПРИХИЛЬНІСТЬ ДО ПОДАЛЬШОГО ЛІКУВАННЯ У ПАЦІЄНТІВ З ІНФАРКТОМ МІОКАРДА","authors":"O. I. Levchyk","doi":"10.11603/2415-8798.2018.2.9199","DOIUrl":null,"url":null,"abstract":"In modern clinical practice, the doctor is increasingly faced with a combination of two or more diseases in one patient. Such states are called comorbid, concomitant pathologies, or associated diseases [1–3]. This is especially true for patients with myocardial infarction (MI), since cardiovascular disease (CVD ) remains one of the main causes of death in Ukraine and in the world (World Heart Federation, WH F, 2017).The aim of the study – to set the frequency and the structure of comorbidity in patients with myocardial infarction (IM) and its effect on adherence to further treatment.Materials and Methods. We examined 152 patients with MI, aged 38 to 89 years, on average (60.66±0.86) years (52 women and 100 men) who were divided according to the Morisky-Green questionnaire by two groups: the first – adherent to treatment (n=77), the second group – not adherent to treatment (n=75). The Charlson and CIRS comorbidity indices were determined.Results and Discussion. Both groups identified risk factors and 84% of the concomitant pathology, with the Charleston index – (5.81±1.78), and CIRS (9.32±2.79) points, the largest proportion of diseases of the digestive system. When comparing between groups for the same amount of comorbid pathology (5.66±0.19) and (5.96±0.24) points of Charlson, p<0.05) in patients in the second group a heavier course with deeper damage to organs and systems (CIRS – (8.23±0.25) versus (10.43±0.34) points, p<0.001), which reduces the level of adherence to the prescribed therapy.Conclusions. Patients with myocardial infarction often have a comorbidity, but with the same number of concomitant diseases in different patients, the severity and depth of damage to organs and systems are different. The present combined pathology has an effect on adherence to therapy. Determining the Charlson and CIRS indices allows you to predict the level of compliance individually for each patient and take measures to increase its level.","PeriodicalId":146679,"journal":{"name":"Вісник наукових досліджень","volume":"79 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Вісник наукових досліджень","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11603/2415-8798.2018.2.9199","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In modern clinical practice, the doctor is increasingly faced with a combination of two or more diseases in one patient. Such states are called comorbid, concomitant pathologies, or associated diseases [1–3]. This is especially true for patients with myocardial infarction (MI), since cardiovascular disease (CVD ) remains one of the main causes of death in Ukraine and in the world (World Heart Federation, WH F, 2017).The aim of the study – to set the frequency and the structure of comorbidity in patients with myocardial infarction (IM) and its effect on adherence to further treatment.Materials and Methods. We examined 152 patients with MI, aged 38 to 89 years, on average (60.66±0.86) years (52 women and 100 men) who were divided according to the Morisky-Green questionnaire by two groups: the first – adherent to treatment (n=77), the second group – not adherent to treatment (n=75). The Charlson and CIRS comorbidity indices were determined.Results and Discussion. Both groups identified risk factors and 84% of the concomitant pathology, with the Charleston index – (5.81±1.78), and CIRS (9.32±2.79) points, the largest proportion of diseases of the digestive system. When comparing between groups for the same amount of comorbid pathology (5.66±0.19) and (5.96±0.24) points of Charlson, p<0.05) in patients in the second group a heavier course with deeper damage to organs and systems (CIRS – (8.23±0.25) versus (10.43±0.34) points, p<0.001), which reduces the level of adherence to the prescribed therapy.Conclusions. Patients with myocardial infarction often have a comorbidity, but with the same number of concomitant diseases in different patients, the severity and depth of damage to organs and systems are different. The present combined pathology has an effect on adherence to therapy. Determining the Charlson and CIRS indices allows you to predict the level of compliance individually for each patient and take measures to increase its level.
在现代临床实践中,医生越来越多地面临两种或两种以上疾病合并在一个病人身上的情况。这种状态被称为共病、伴随病理或相关疾病[1-3]。对于心肌梗死(MI)患者尤其如此,因为心血管疾病(CVD)仍然是乌克兰和世界上死亡的主要原因之一(世界心脏联合会,WH F, 2017)。本研究的目的是确定心肌梗死(IM)患者合并症的频率和结构及其对进一步治疗依从性的影响。材料与方法。我们检查了152例心肌梗死患者,年龄38 - 89岁,平均(60.66±0.86)岁(52名女性和100名男性),根据Morisky-Green问卷分为两组:第一组-坚持治疗(n=77),第二组-不坚持治疗(n=75)。测定Charlson和CIRS合并症指数。结果和讨论。两组均发现了危险因素和84%的伴随病理,其中查尔斯顿指数为(5.81±1.78)分,CIRS为(9.32±2.79)分,消化系统疾病所占比例最大。当两组患者共病病理(5.66±0.19)分和(5.96±0.24)分Charlson, p<0.05)比较时,第二组患者病程较重,器官和系统损害较深(CIRS -(8.23±0.25)分和(10.43±0.34)分,p<0.001),降低了对规定治疗的依从性。心肌梗死患者往往有合并症,但相同数量的合并症在不同的患者身上,对器官和系统的损害程度和深度不同。目前的联合病理对治疗的依从性有影响。确定Charlson和CIRS指数使您可以单独预测每位患者的依从性水平,并采取措施提高其水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信